Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Current Pharmaceutical Design
|
March 28, 2014
Preoperative levosimendan. A new way for organoprotection
Jose L Orriach Guerrero, A Ramirez Fernandez, P Iglesias, et al.
International Journal of Molecular Sciences
|
December 2, 2020
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer
Cristina Nieto-Jimenez, Ana Alcaraz-Sanabria, Sandra Martinez-Canales, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
December 9, 2014
Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating human blood
Gines Escolar, Eduardo Arellano-Rodrigo, Irene Lopez-Vilchez, et al.
Plos One
|
April 17, 2019
Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors
Sara Morcillo-Garcia, Maria Del Mar Noblejas-Lopez, Cristina Nieto-Jimenez, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
October 7, 2010
Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy
James Rochon, Connie W Bales, Eric Ravussin, et al.
Plos One
|
December 14, 2011
Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC
Eva M Galan-Moya, Miguel A de la Cruz-Morcillo, Maria Llanos Valero, et al.
International Journal of Molecular Sciences
|
January 28, 2026
<i>Rosa x hybrida</i>: A New Tool for Functional Food Development with Triple-Negative Breast Antitumoral Implications
Lorenzo Rivas-Garcia, Tamara Y Forbes-Hernández, Pablo Cristóbal-Cueto, et al.
Cancer Letters
|
August 1, 2020
Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer
Cristina Nieto-Jimenez, Eva M Galan-Moya, Veronica Corrales-Sanchez, et al.
International Journal of Cancer
|
September 26, 2007
c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy
Eva M Galan-Moya, Javier Hernandez-Losa, Clara I Aceves Luquero, et al.
ESMO Open
|
September 2, 2025
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial
T Pascual, G Villacampa, M Oliveira, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Current Pharmaceutical Design
|
March 28, 2014
Preoperative levosimendan. A new way for organoprotection
Jose L Orriach Guerrero, A Ramirez Fernandez, P Iglesias, et al.
International Journal of Molecular Sciences
|
December 2, 2020
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer
Cristina Nieto-Jimenez, Ana Alcaraz-Sanabria, Sandra Martinez-Canales, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
December 9, 2014
Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating human blood
Gines Escolar, Eduardo Arellano-Rodrigo, Irene Lopez-Vilchez, et al.
Plos One
|
April 17, 2019
Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors
Sara Morcillo-Garcia, Maria Del Mar Noblejas-Lopez, Cristina Nieto-Jimenez, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
October 7, 2010
Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy
James Rochon, Connie W Bales, Eric Ravussin, et al.
Plos One
|
December 14, 2011
Balance between MKK6 and MKK3 mediates p38 MAPK associated resistance to cisplatin in NSCLC
Eva M Galan-Moya, Miguel A de la Cruz-Morcillo, Maria Llanos Valero, et al.
International Journal of Molecular Sciences
|
January 28, 2026
<i>Rosa x hybrida</i>: A New Tool for Functional Food Development with Triple-Negative Breast Antitumoral Implications
Lorenzo Rivas-Garcia, Tamara Y Forbes-Hernández, Pablo Cristóbal-Cueto, et al.
Cancer Letters
|
August 1, 2020
Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer
Cristina Nieto-Jimenez, Eva M Galan-Moya, Veronica Corrales-Sanchez, et al.
International Journal of Cancer
|
September 26, 2007
c-Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin-based therapy
Eva M Galan-Moya, Javier Hernandez-Losa, Clara I Aceves Luquero, et al.
ESMO Open
|
September 2, 2025
Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial
T Pascual, G Villacampa, M Oliveira, et al.
Page
of 11